CLINICAL FEATURES AND MODERN METHODS OF TREATMENT OF PSORIASIS  IN CHILDREN

Ahrorbek Abdurahmanov Avazbek ugli

Authors

Ahrorbek Abdurahmanov Avazbek ugli Department of Dermatovenerology, Andijan State Medical Institute, Uzbekistan

Keywords:

Psoriasis, children, clinical forms, clinical features, local therapy, systemic treatment, topical treatment

Abstract

Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by hyperproliferation and abnormal differentiation of keratinocytes. Although more commonly diagnosed in adults, pediatric psoriasis represents a significant subset of cases, affecting approximately 0.5%–2% of children worldwide. Early onset of psoriasis can have substantial psychosocial and medical implications, underscoring the importance of prompt diagnosis and appropriate management [1,2].

References

Bronckers, I. M. G. J., Paller, A. S., van Geel, M. J., et al. (2017). Treating psoriasis in children and adolescents: Expert recommendations. Pediatr Dermatol, 34(5), 575–584.

Paller, A. S., Siegfried, E. C., Langley, R. G., et al. (2016). Etanercept treatment for children and adolescents with plaque psoriasis. J Am Acad Dermatol, 54(4), 712–720.

Mahé, E., Bodemer, C. (2017). Management of pediatric psoriasis. Clin Exp Dermatol, 42(2), 131–137.

Bakhodirovna, Mirzakarimova Dildora, and Abdukodirov Sherzodjon Taxirovich. "CHARACTERISTICS OF RHINOVIRUS INFECTION." International journal of medical sciences 4, no. 08 (2024): 55-59.

Landells, I., Marano, C., Hsu, M. C., et al. (2015). Ustekinumab in adolescent patients with moderate-to-severe plaque psoriasis: Efficacy, safety, and pharmacokinetics from the randomized CADMUS study. J Am Acad Dermatol, 73(4), 594–603.